Market Tracker

07/24 6:05pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

3.60
Data as of 4:02pm ET
 +0.23 / +6.82%
Today’s Change
3.16
Today|||52-Week Range
5.60
-7.46%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close3.37
Today’s open3.53
Day’s range3.52 - 3.65
Volume284,926
Average volume (3 months)230,262
Market cap$315.5M
Dividend yield--
Data as of 4:02pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GNCAGenocea Biosciences ...-0.26-1.44%
ENZYEnzymotec Ltd+0.08+0.54%
RDUSRadius Health Inc+0.08+0.83%
RNAProsensa Holding NV+0.33+3.48%
Data as of 3:59pm ET, 07/24/2014

Financials

Next reporting dateSeptember 3, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts